Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells

We recently identified nitroxoline as a repurposed drug candidate in pancreatic cancer (PC) showing a dose-dependent antiproliferative activity in different PC cell lines. This antibiotic is effective in several in vitro and animal cancer models. To date, the mechanisms of nitroxoline anticancer act...

Descripción completa

Detalles Bibliográficos
Autores principales: Veschi, Serena, Ronci, Maurizio, Lanuti, Paola, De Lellis, Laura, Florio, Rosalba, Bologna, Giuseppina, Scotti, Luca, Carletti, Erminia, Brugnoli, Federica, Di Bella, Maria Cristina, Bertagnolo, Valeria, Marchisio, Marco, Cama, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018951/
https://www.ncbi.nlm.nih.gov/pubmed/32054977
http://dx.doi.org/10.1038/s41598-020-59492-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018951/
https://www.ncbi.nlm.nih.gov/pubmed/32054977
http://dx.doi.org/10.1038/s41598-020-59492-4

Ejemplares similares